When Lynda Horn, a 70-year-old woman diagnosed with breast cancer, discovered that she would undergo chemotherapy treatment, she was most concerned about the looming mastectomy and how it would alter her appearance. She brushed off the idea of hair loss, expecting her hair to eventually grow back. However, after her first treatment, Lynda’s blonde bob began to thin out and fall out in clumps. Devastated, she took matters into her own hands and shaved her head. Four years later, Lynda remains virtually bald, with only an inch of hair that reveals her scalp. Lynda’s experience is not uncommon, as studies estimate that around three in every 100 chemotherapy patients will suffer permanent hair loss.
Shirley Ledlie, the founder of support group Ahead Of Our Time, who experienced permanent hair loss from docetaxel treatment in 2005, emphasizes the importance of doctors informing patients about the possibility of permanent hair loss and offering potential ways to reduce this risk. Sadly, many patients have shared their stories of being falsely assured that their hair would return. Alopecia, resulting from chemotherapy, can be emotionally devastating and a constant reminder of one’s battle with cancer.
Lynda, who is now cancer-free, confesses that her hair loss has greatly impacted her life. While she can conceal her mastectomy with a bra, she cannot hide her hair loss, making her feel self-conscious and unable to move forward. The Mail on Sunday recently highlighted readers’ experiences of hair loss due to chemotherapy, revealing how doctors often downplay the potential for permanent hair loss. Some patients, 12 years after treatment, have experienced no regrowth and must rely on wigs or hats to hide their appearance. Others struggle with patchy regrowth and suffer from sunburn on their exposed scalps, leading to a decline in self-confidence.
While a consultant oncologist believes that permanent hair loss is rare, Professor Andrew Wardley, an oncologist and chairman of the Association of Cancer Physicians, argues that the prevalence may be higher than current estimates suggest. He believes that docetaxel has the potential to completely destroy hair follicles. However, Professor Wardley sympathizes with doctors who fail to emphasize the possibility of long-term hair loss, recognizing that patients may be overwhelmed by the information provided during their diagnosis.
Nurse Caroline Geraghty, a patient adviser for Cancer Research UK, acknowledges that patients are given leaflets about potential side effects and encouraged to discuss any concerns. However, bombarding patients with warnings can be overwhelming. Cancer nurse Julia Frater adds that doctors often prioritize discussing life-threatening complications, prioritizing patient safety.
Many chemotherapy drugs, including taxanes like docetaxel, frequently used in breast cancer treatment, can lead to hair loss. These drugs destroy rapidly dividing cells, such as cancer cells, but also affect healthy cells in the body that constantly renew, including hair follicles. Side effects of chemotherapy may include nausea, vomiting, muscle and joint pain, skin reactions, mouth sores, fluid retention, taste changes, and fatigue. While most side effects subside after treatment, some types of chemotherapy are harsher on certain tissues. For example, docetaxel is known for its adverse effects on hair follicles.
Information provided to patients regarding the possibility of permanent hair loss due to chemotherapy should be clearer. Macmillan Cancer Support acknowledges that hair usually grows back after treatment but fails to mention that it can occasionally be permanent. Similarly, Cancer Research UK vaguely states that hair will usually grow back but may be softer, a different color, or curlier. This lack of clarity can leave patients feeling blindsided by the long-term consequences of treatment.
Hayley Purnell, a carer from Harrogate, experienced permanent hair loss at just 45 years old after being diagnosed with breast cancer. She was assured by her healthcare team that her hair would grow back within a few months, but she was devastated to discover that it was not the case. The emotional toll of hair loss can be significant, further impacting a patient’s confidence and self-esteem.
Overall, it is crucial for healthcare professionals to fully inform patients about the potential for permanent hair loss during chemotherapy treatment. Providing clear and honest information empowers patients to make informed decisions and better cope with the emotional and physical challenges they may face.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
